Moderna Stock News

Fears of the new Omicron Covid variant slammed the stock market Friday. Here''s what investors should be doing now. Li Auto earnings are on tap.

Manufacturers of COVID-19 vaccines used in the US say they are taking quick action after recent revelations of the South African ''Nu'' variant, and its high infectiousness and ability to evade vaccines.

Stocks that traded heavily or had substantial price changes Friday: Delta, Carnival fall; Moderna, Clorox rise

Purus Wealth Management LLC lowered its stake in shares of Moderna, Inc. (NASDAQ:MRNA) by 1.4% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 8,216 shares of the companys stock after selling 116 shares during the quarter. Moderna makes up approximately 2.2% []

Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: The Morning News Call newsletter: The Dow dragged Wall Streets main indexes lower on Friday, with travel, bank and commodity-linked stocks bearing the brunt of a selloff triggered by the discovery of a new and possibly vaccine-resistant coronavirus variant. At 10:34 [] The post Apple, Macys, Moderna | Reuters appeared first on TECHTELEGRAPH .

The post Moderna, United Airlines, Zoom and more appeared on BitcoinEthereumNews.com . Modernas sign is seen outside of their headquarters in Cambridge, MA on March 11, 2021. Boston Globe | Getty Images Check out the companies making headlines in midday trading Friday:

Two new variants of COVID-19 which appear to have emerged in Southern Africa are raising extremely serious concerns around the world. The variantsknown as C.1.2 and B.1.1.529appear to have a worrisome combination of changes, including changes that could make them highly evasive of antibodies from both vaccines and previous infections. Of particular concern: these variants appear to be more contagious than the already highly infectious delta, with the B.1.1.529 variant in particular going from a small cluster of cases, to local dominance, almost overnight. The B.1.1.529 variant, which could gain the label nu following a World Health Organization meeting on Friday, is raising concerns great enough that both Israel and the U.K. have moved quickly to ban travel to and from the region where this variant has been identified. First identified in Botswana , the variant was initially tagged as a very small cluster (4 cases in Botswana, 77 in South Africa, and 1 case in Hong Kong). However, as virologist Tom Peacock of Imperial College quickly noted, the number of mutations seen in this variant are really awful and give it a horrific spike profile . Other variants showing extreme mutations on the spike protein have been identified before, and several of these have contained changes that suggested they could be more evasive of antibodies from existing vaccines and past infections.

As many as 70,568 people have received the coronavirus jab with either the Pfizer, Moderna, AstraZeneca or Johnson&Johnson vaccine in the past 24 hours, the National COVID Vaccination Coordination Committee (CNCAV) informs on Friday. Citete mai departe

Moderna Inc (NASDAQ: MRNA ) shares are up over 20% during the trading session on Friday. There are no direct news reports from the Company, so there are external factors at play. The share price is apparently connected to the new COVID-19 variant. Investors believe that there will be more significant and longer-term demand for the vaccine that Moderna has developed. Full story available on Benzinga.com

Shares of Moderna Inc (NASDAQ: MRNA) are up 25% this morning after the World Health Organisation called a special meeting to assess if the new heavily mutated Coronavirus variant could be more contagious or resistant than the delta variant. The stock is still down about 30% from its year-to-date high Moderna rose to prominence last [] The post Heres why Moderna shares are up 25% on Friday morning appeared first on Invezz.

Moderna (NASDAQ:MRNA) and Kiromic BioPharma (NASDAQ:KRBP) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, institutional ownership, earnings, valuation and profitability. Earnings and Valuation This table compares Moderna and Kiromic BioPharmas gross revenue, earnings per share and valuation. [] The post Head to Head Review: Moderna (NASDAQ:MRNA) versus Kiromic BioPharma (NASDAQ:KRBP) appeared first on ETF Daily News .

Vaccine stocks Pfizer, BioNTech and Moderna popped Friday as scientists grappled with a new Covid variant first detected in South Africa.

Black Friday Bedlam Means Kiss The Taper Goodbye Submitted by QTR''s Fringe Finance It’s semi-hilarious that when Covid first occurred at the beginning of 2020, I couldn’t get a single soul to listen to me when I warned that the market would eventually react negatively. Now, entire continents stop all travel, immediately consider lockdowns and markets sell off 2% every time a new variant makes its way into the news cycle. Just hours after Goldman Sachs made the dumbass move of predicting a quicker than expected taper , index futures are getting destroyed on news of a new Covid variant out of South Africa - days after I warned that the market could wind up getting its salad tossed heading into the new year. That prediction was for reasons other than another Covid variant, but I stand by my analysis. Just three days ago, I wrote: I’m often one of the first people to joke about how nonsensical the idea of a Santa Claus rally is, but it puts the idea of a rising market over the holidays into everybody’s head, every year.